$17.93
-1.21-6.34%
In chiusura: Nov 18, 4:00 PM EST

SELLAS Life Sciences Gr (SLS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.05 | $-0.05 | 0.00 % |
| Q2 | Aug 11, 2026 | $-0.05 | $-0.04 | -25.0 % |
| Q1 | May 12, 2026 | $-0.05 | $-0.06 | 16.7 % |
| Q4 | Mar 19, 2026 | $-0.05 | $-0.06 | 16.7 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2023 | $0 | $8.67M | -100.0 % |
| Q2 | Aug 10, 2023 | $0 | $3.25M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $-0.04 | $-0.06 | $-0.06 |
| Actual | $-0.05 | $-0.05 | $-0.05 | $-0.05 |
| Surprise | 0.00% | -25.0% | +16.7% | +16.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.05 |
| Revenue | |
| Consensus | — |